Linda Rhodes - Net Worth and Insider Trading
Linda Rhodes Net Worth
The estimated net worth of Linda Rhodes is at least $2 Million dollars as of 2024-11-13. Linda Rhodes is the CHIEF SCIENTIFIC OFFICER of Aratana Therapeutics Inc and owns about 423,205 shares of Aratana Therapeutics Inc (PETX) stock worth over $2 Million. Linda Rhodes is the Director of Zoetis Inc and owns about 1,468 shares of Zoetis Inc (ZTS) stock worth over $255,373. Linda Rhodes is also the Director of ImmuCell Corp and owns about 7,157 shares of ImmuCell Corp (ICCC) stock worth over $26,123. Details can be seen in Linda Rhodes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Linda Rhodes has not made any transactions after 2020-09-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Linda Rhodes
Linda Rhodes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Linda Rhodes owns 3 companies in total, including Zoetis Inc (ZTS) , ImmuCell Corp (ICCC) , and Aratana Therapeutics Inc (PETX) .
Click here to see the complete history of Linda Rhodes’s form 4 insider trades.
Insider Ownership Summary of Linda Rhodes
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZTS | Zoetis Inc | 2020-09-04 | director |
| ICCC | ImmuCell Corp | 2016-01-29 | director |
| PETX | Aratana Therapeutics Inc | 2015-04-27 | CHIEF SCIENTIFIC OFFICER |
Linda Rhodes Latest Holdings Summary
Linda Rhodes currently owns a total of 3 stocks. Among these stocks, Linda Rhodes owns 423,205 shares of Aratana Therapeutics Inc (PETX) as of April 27, 2015, with a value of $2 Million and a weighting of 88.09%. Linda Rhodes owns 1,468 shares of Zoetis Inc (ZTS) as of September 4, 2020, with a value of $255,373 and a weighting of 10.8%. Linda Rhodes also owns 7,157 shares of ImmuCell Corp (ICCC) as of January 29, 2016, with a value of $26,123 and a weighting of 1.11%.
Latest Holdings of Linda Rhodes
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PETX | Aratana Therapeutics Inc | 2015-04-27 | 423,205 | 4.92 | 2,082,169 |
| ZTS | Zoetis Inc | 2020-09-04 | 1,468 | 173.96 | 255,373 |
| ICCC | ImmuCell Corp | 2016-01-29 | 7,157 | 3.65 | 26,123 |
Holding Weightings of Linda Rhodes
Linda Rhodes Form 4 Trading Tracker
According to the SEC Form 4 filings, Linda Rhodes has made a total of 0 transactions in Aratana Therapeutics Inc (PETX) over the past 5 years. The most-recent trade in Aratana Therapeutics Inc is the sale of 15,000 shares on April 27, 2015, which brought Linda Rhodes around $225,000.
According to the SEC Form 4 filings, Linda Rhodes has made a total of 1 transactions in Zoetis Inc (ZTS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Zoetis Inc is the sale of 1,087 shares on September 4, 2020, which brought Linda Rhodes around $173,007.
According to the SEC Form 4 filings, Linda Rhodes has made a total of 0 transactions in ImmuCell Corp (ICCC) over the past 5 years. The most-recent trade in ImmuCell Corp is the acquisition of 2,857 shares on January 29, 2016, which cost Linda Rhodes around $14,999.
Insider Trading History of Linda Rhodes
- 1
Linda Rhodes Trading Performance
GuruFocus tracks the stock performance after each of Linda Rhodes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Linda Rhodes is 4.7%. GuruFocus also compares Linda Rhodes's trading performance to market benchmark return within the same time period. The performance of stocks bought by Linda Rhodes within 3 months outperforms 3 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Linda Rhodes's insider trading performs compared to the benchmark.
Performance of Linda Rhodes
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.08 | | | | | |
| Relative Return to S&P 500(%) | -1.18 | | | | | |
Linda Rhodes Ownership Network
Ownership Network List of Linda Rhodes
Ownership Network Relation of Linda Rhodes
Linda Rhodes Owned Company Details
What does Zoetis Inc do?
Who are the key executives at Zoetis Inc?
Linda Rhodes is the director of Zoetis Inc. Other key executives at Zoetis Inc include Executive Vice President Roxanne Lagano , Executive Vice President Kristin C Peck , and Executive Vice President Heidi C. Chen .
Zoetis Inc (ZTS) Insider Trades Summary
Over the past 18 months, Linda Rhodes made no insider transaction in Zoetis Inc (ZTS). Other recent insider transactions involving Zoetis Inc (ZTS) include a net sale of 14,018 shares made by Roxanne Lagano , a net sale of 52,000 shares made by Kristin C Peck , and a net sale of 9,905 shares made by Heidi C. Chen .
In summary, during the past 3 months, insiders sold 0 shares of Zoetis Inc (ZTS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 78,472 shares of Zoetis Inc (ZTS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 78,472 shares.
Zoetis Inc (ZTS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zoetis Inc Insider Transactions
Linda Rhodes Mailing Address
Above is the net worth, insider trading, and ownership report for Linda Rhodes. You might contact Linda Rhodes via mailing address: 56 Evergreen Drive, Portland Me 04103.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
